Independent Clinical Impacts of Procedural Complexity on Ischemic and Bleeding Events in Patients with Acute Myocardial Infarction: Long-Term Clinical Study
Abstract:This study aimed to investigate the relationship between a complex percutaneous coronary intervention (C-PCI) and long-term clinical outcomes in the AMI cohort. A total of 10,329 patients were categorized into the C-PCI and non-C-PCI groups. The primary ischemic endpoint was a composite of major adverse cardiac events (MACEs, cardiac death, myocardial infarction, stent thrombosis and revascularization). The primary bleeding endpoint was the risk of overt bleeding (BARC 2, 3 or 5). The median follow-up duration… Show more
“…This work highlights that procedure complexity can be identified as an independent risk factor for worse outcome during long-term follow-up periods. As a result, individual decision making and the need for large-volume tests regarding antithrombotic therapy, especially in the setting of complex coronary interventions, have been discussed [13].…”
The treatment and burden of patients with severe ischemic heart disease, whether acute or chronic, remain some of the greatest challenges in cardiology [...]
“…This work highlights that procedure complexity can be identified as an independent risk factor for worse outcome during long-term follow-up periods. As a result, individual decision making and the need for large-volume tests regarding antithrombotic therapy, especially in the setting of complex coronary interventions, have been discussed [13].…”
The treatment and burden of patients with severe ischemic heart disease, whether acute or chronic, remain some of the greatest challenges in cardiology [...]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.